A. Langner et al., INVESTIGATIONS ON THE BIOTRANSFORMATION O F THE ANTICONVULSANT 4-P-CHLOROPHENYLPYRROLE-3-MORPHOLINO-2-CARBOXYLIC ACID METHYL-ESTER (AWD-140-076), Die Pharmazie, 48(11), 1993, pp. 849-853
4-p-Chlorphenylpyrrole-3-morpholino-2-carboxylic acid methylester (1;
AWD 140-076) is a substance with anticonvulsive properties. After p.o.
administration in male wistar rats many metabolites in relatively sma
ll concentration are excreted in urine and faeces, six of them could b
e isolated and identified as quantitative dominating compounds. Compou
nd 1 is attacked in different sites of the molecule by the cytochrome
P-450 system. At the morpholine ring N- and O-dealkylation reactions t
ake place leading to the cleavage of the ring. After that a stepwise d
egradation by oxidative and reductive processes occurs. Further reacti
ons concern the N-oxidation of the morpholine nitrogen as well as the
hydroxylation of the pyrrole skeleton forming the main metabolites. 5
metabolites are also present as sulfate or glucuronide conjugates. The
quantity ratio of the phase I to phase II metabolites amounts to 9:1.
In the in vitro test system isolated perfused rat liver and rat hepat
ocytes culture solely the two main metabolites are formed. Compound 1
is characterized by enzyme inducing activities. The oxidative demethyl
ation of p-nitroanisole is increased 4fold after pretreatment.